World's Best Scientists 2026 revealed!
Philip S. Wells

Philip S. Wells

D-Index & Metrics

Medicine

D-Index
105
Citations
66166
World Ranking
6649
National Ranking
254

Overview

Philip S. Wells is affiliated with the Ottawa Hospital in Canada and has a research focus centered on medicine, with a total of 184 publications. Their work predominantly spans internal medicine, cardiology and cardiovascular medicine, emergency medical services, hematology, and epidemiology.

The primary areas of research for Philip S. Wells include venous thromboembolism diagnosis and management, atrial fibrillation management and outcomes, central venous catheters and hemodialysis, blood coagulation and thrombosis mechanisms, acute myocardial infarction research, acute ischemic stroke management, and antiplatelet therapy and cardiovascular diseases.

Frequent co-authors in Philip S. Wells's publications are:

  • Marc Carrier (33 publications)
  • Ranjeeta Mallick (23 publications)
  • Grégoire Le Gal (18 publications)
  • Tzu-Fei Wang (18 publications)
  • Menno V. Huisman (15 publications)

The venues where Philip S. Wells has published most frequently include:

  • Journal of Thrombosis and Haemostasis (15 publications)
  • Thrombosis Research (12 publications)
  • Blood (12 publications)
  • Research and Practice in Thrombosis and Haemostasis (7 publications)
  • European Heart Journal (5 publications)

Among recent notable papers authored or co-authored, the following are highlighted:

  • Antithrombotic Therapy for VTE Disease, 2024, CHEST Journal
  • Antithrombotic Therapy for VTE Disease, 2021, CHEST Journal
  • Executive Summary, 2021, CHEST Journal
  • Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism, 2021, Annals of Internal Medicine
  • Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial, 2021, BMJ

Best Publications

  • Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

    Clive Kearon;Elie A. Akl;Anthony J. Comerota;Paolo Prandoni

  • Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report

    Clive Kearon;Elie A. Akl;Elie A. Akl;Joseph Ornelas;Allen Blaivas

  • Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer

    Philip S. Wells;David R. Anderson;Marc Rodger;Jeffrey S. Ginsberg

  • Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis

    Philip S. Wells;David R. Anderson;Marc Rodger;Melissa Forgie

  • Value of assessment of pretest probability of deep-vein thrombosis in clinical management

    Philip S Wells;David R Anderson;Janis Bormanis;Fred Guy

  • Systematic overview of warfarin and its drug and food interactions.

    Anne M. Holbrook;Jennifer A. Pereira;Renee Labiris;Heather McDonald

  • A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

    Clive Kearon;Michael Gent;Michael Gent;Jack Hirsh;Jack Hirsh;Jeffrey Weitz

  • Use of a clinical model for safe management of patients with suspected pulmonary embolism.

    Philip S. Wells;Jeffrey S. Ginsberg;David R. Anderson;Clive Kearon

  • Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer.

    Philip S. Wells;David R. Anderson;Marc Rodger;Ian Stiell

  • Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

    Clive Kearon;Jeffrey S. Ginsberg;Michael J. Kovacs;David R. Anderson

  • Accuracy of clinical assessment of deep-vein thrombosis

    PhilipS. Wells;Jack Hirsh;DavidR. Anderson;AnthonyW.A. Lensing

  • Risk for heparin-induced thrombocytopenia with unfractionated and low- molecular-weight heparin thromboprophylaxis: a meta-analysis

    Nadine Martel;James Lee;Philip S. Wells

  • Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

    Shannon M. Bates;Roman Jaeschke;Scott M. Stevens;Steven Goodacre

  • Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

    Jeffrey I. Weitz;Anthonie W.A. Lensing;Martin H. Prins;Rupert Bauersachs

  • Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

    Marc Carrier;Karim Abou-Nassar;Ranjeeta Mallick;Vicky Tagalakis

  • Interactions of Warfarin with Drugs and Food

    Philip S. Wells;Anne M. Holbrook;N. Renee Crowther;Jack Hirsh

  • Does This Patient Have Deep Vein Thrombosis

    Sonia S. Anand;Philip S. Wells;Dereck Hunt;Dereck Hunt;Pat Brill-Edwards

  • Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial

    David R Anderson;Susan R Kahn;Marc A Rodger;Michael J Kovacs

  • Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

    Martin H Prins;Anthonie Wa Lensing;Rupert Bauersachs;Bonno van Bellen

  • Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

    Marc A. Rodger;Susan R. Kahn;Philip S. Wells;David A. Anderson

Frequent Co-Authors

Marc A. Rodger
Marc A. Rodger Ottawa Hospital
Marc Carrier
Marc Carrier Ottawa Hospital
Susan R. Kahn
Susan R. Kahn McGill University
Clive Kearon
Clive Kearon McMaster University
Jeffrey I. Weitz
Jeffrey I. Weitz McMaster University
Mark Crowther
Mark Crowther McMaster University
Jeffrey S. Ginsberg
Jeffrey S. Ginsberg McMaster University
Paolo Prandoni
Paolo Prandoni University of Padua
Martin H. Prins
Martin H. Prins Maastricht University
Henri Bounameaux
Henri Bounameaux University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative routes in healthcare can expand your opportunities beyond a traditional MD. Many professionals pursue a Master of Healthcare Administration. If you are interested, consider a cahme accredited online mha degree, which is recognized for quality and advances leadership roles in hospitals, clinics, and other health organizations.

For nurses hoping to further their education, online programs now offer flexible options. If you want to earn your bachelor's degree but need to balance work and study, an rn to bsn online no clinicals program removes the need for additional clinical rotations, smoothing the transition for working RNs.

Advanced nursing degrees can also be completed at an accelerated pace—review the shortest msn to dnp program options to quickly move into high-level nurse practitioner or educator roles. If program difficulty is a concern, searching for the easiest dnp program reddit discussions can offer student insights on balancing rigor and flexibility.

Whether your interest is in administration, nursing, or specialized practice, a range of online healthcare degrees can help you carve out a rewarding career path in the U.S.

Best Scientists Citing Philip S. Wells

Trending Scientists